KIR2DS2 expression identifies NK cells with enhanced anti-cancer activity

Natural killer (NK) cells are promising cellular therapeutics against haematological and solid malignancies. Immunogenetic studies have identified that various activating killer cell immunoglobulin-like receptors (KIR) are associated with cancer outcomes. Specifically, KIR2DS2 has been associated wi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Immunol
Päätekijät: Blunt, Matthew D., Pulido, Andres Vallejo, Fisher, Jack G., Graham, Lara V., Doyle, Amber DP., Fulton, Rebecca, Carter, Matthew J., Polak, Marta, Johnson, Peter WM., Cragg, Mark S., Forconi, Francesco, Khakoo, Salim I.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2022
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613074/
https://ncbi.nlm.nih.gov/pubmed/35768150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.2101139
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia